Skip to Main Content

Paper Details

Genomic Biomarkers Associated with Response to Induction Chemotherapy in Patients with Localized Pancreatic Ductal Adenocarcinoma.
1
2023
CDKN2A, FOLFIRINOX, Genomic, KRAS, Localized Pancreatic Ductal Adenocarcinoma, PDAC, Patients, SMAD4, TP53, driver genes, gemcitabine, nab, nab-paclitaxel, paclitaxel, pancreatic ductal adenocarcinoma, patient, patients, somatic genomic
Author NameAffiliation
Mithat GonenMemorial Sloan Kettering Cancer Center
  • 1 - 1

Datasets

Release 1.2